RE-CELLULARIZATION VIA ELECTROPORATION THERAPY (RECET) COMBINED WITH GLP-1RA TO REPLACE INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES 6 MONTHS RESULTS OF THE EMINENT STUDY

被引：0
|
作者：
Busch, Celine [1 ]
Meiring, Suzanne [1 ]
Van Baar, Annieke [1 ]
Holleman, Frits [1 ]
Nieuwdorp, Max [1 ]
Bergman, Jacques [1 ]
机构：
[1] Amsterdam UMC Locatie AMC, Amsterdam, Netherlands
来源：
GASTROINTESTINAL ENDOSCOPY | 2023年 / 97卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1272
引用
收藏
页码：AB760 / AB760
页数：1
相关论文
共 50 条
  • [31] What are the early metabolic effects of combining duodenal exclusion and glucagon-like peptide 1 receptor agonist (GLP-1RA) therapy in patients with Type 2 diabetes?
    Sen Gupta, P.
    Amiel, S. A.
    McGowan, B. M.
    Drummond, R. S.
    Bajwa, R. S.
    Blann, A. D.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2015, 32 : 98 - 98
  • [32] Efficacy and safety of IDegLira (combination of insulin degludec and liraglutide) in insulin-naive patients with Type 2 diabetes inadequately controlled on glucagon-like peptide-1 receptor agonist(GLP-1RA) therapy
    Viljoen, A.
    Linjawi, S.
    Bode, B. W.
    Chaykin, L. B.
    Courreges, J-P
    Handelsman, Y.
    Lehmann, L. M.
    Mishra, A.
    Simpson, R. W.
    DIABETIC MEDICINE, 2016, 33 : 63 - 64
  • [33] HEALTH CARE COSTS AMONG TYPE 2 DIABETES MELLITUS PATIENTS INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1RA) THERAPY
    Johnston, S. S.
    Nguyen, H.
    Felber, E.
    Cappell, K.
    Nelson, J.
    Chu, B. C.
    Kalsekar, I
    VALUE IN HEALTH, 2014, 17 (03) : A244 - A244
  • [34] The impact of GLP-1 analogue liraglutide on type 2 diabetes patients with and without insulin therapy
    Haq, Z.
    Reidy, Y.
    Dempsey, M.
    Reidy, C.
    Keogh, A. M.
    Hoashi, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S491 - S492
  • [35] Glucagon like peptide-1 receptor agonist (GLP-1RA) therapy in management of type 2 diabetes: choosing the right agent for individualised care
    Htike, Zin Zin
    Zaccardi, Francesco
    Chatterjee, Sudesna
    Khunti, Kamlesh
    Davies, Melanie J.
    BRITISH JOURNAL OF DIABETES, 2016, 16 (03): : 128 - +
  • [36] Costs and clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes: results from the TREAT study
    Benroubi, M.
    Schmitt, H.
    Cleall, S.
    Aloumanis, K.
    Lee, L. J.
    DIABETOLOGIA, 2011, 54 : S414 - S414
  • [37] Durable effects of duodenal ablation using electroporation combined with Semaglutide to eliminate insulin therapy in patients with type 2 diabetes; 24-month results
    Busch, C. B. E.
    van den Hoek, K.
    van Baar, A. C. G.
    Meiring, S.
    Holleman, F.
    Nieuwdorp, M.
    Bergman, J. J. G.
    DIABETOLOGIA, 2024, 67 : S334 - S335
  • [38] Efficacy and Safety of IDegLira (Combination of Insulin Degludec plus Liraglutide), in Insulin-Naive Patients with T2D Uncontrolled on GLP-1 Receptor Agonist (GLP-1RA) Therapy
    Linjawi, Sultan
    Bode, Bruce W.
    Chaykin, Louis B.
    Courreges, Jean-Pierre
    Handelsman, Yehuda
    Lehmann, Lucine
    Mishra, Abhishek
    Simpson, Richard W.
    DIABETES, 2015, 64 : A255 - A255
  • [39] Add-on treatment of GLP-1 based therapy in patients with type 2 diabetes treated with insulin: an observational study
    Zandee, W. T.
    Sleddering, M. A.
    Jazet, I.
    Bootsma, A. H.
    Geelhoed-Duijvestijn, P. H. L.
    DIABETOLOGIA, 2012, 55 : S299 - S299
  • [40] The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study
    Wu, Tingting
    Wong, Carlos K. H.
    Tang, Eric H. M.
    Man, Kenneth K. C.
    Wong, Simon K. H.
    Au, Ivan Chi Ho
    Tse, Emily T. Y.
    Chan, Esther W. Y.
    Grieve, Eleanor
    Wu, Olivia
    Ng, Enders K. W.
    Wong, Ian C. K.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2022, 18 (06) : 762 - 771
12345